Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
GENE:
NSD1 (Nuclear Receptor Binding SET Domain Protein 1)
i
Other names:
NSD1, Nuclear Receptor Binding SET Domain Protein 1, ARA267, KMT3B, Histone-Lysine N-Methyltransferase H3 Lysine-36 Specific, Nuclear Receptor-Binding SET Domain-Containing Protein 1, Androgen Receptor-Associated Protein Of 267 KDa, Androgen Receptor Coactivator 267 KDa Protein, NR-Binding SET Domain-Containing Protein, Lysine N-Methyltransferase 3B, H3-K36-HMTase, Histone-Lysine N-Methyltransferase H3 Lysine-36 And H4 Lysine-20 Specific, Truncated Nuclear Receptor Binding SET Domain Protein 1, Nuclear Receptor SET Domain-Containing Protein 1, Androgen Receptor-Associated Coregulator 267, Sotos Syndrome, H4-K20-HMTase, FLJ22263, SOTOS1, SOTOS, NSD1, STO
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
64324
Associations
(6)
News
Trials
VERI cancer hierarchy
Reset Filters
NSD1 mutation
Solid Tumor
NSD1 mutation
Solid Tumor
cisplatin
Sensitive: C3 – Early Trials
cisplatin
Sensitive
:
C3
cisplatin
Sensitive: C3 – Early Trials
cisplatin
Sensitive
:
C3
NUP98-NSD1 fusion + FLT3-ITD mutation
Acute Myelogenous Leukemia
NUP98-NSD1 fusion + FLT3-ITD mutation
Acute Myelogenous Leukemia
sorafenib
Sensitive: C3 – Early Trials
sorafenib
Sensitive
:
C3
sorafenib
Sensitive: C3 – Early Trials
sorafenib
Sensitive
:
C3
NUP98-NSD1 fusion + FLT3-ITD mutation
Acute Myelogenous Leukemia
NUP98-NSD1 fusion + FLT3-ITD mutation
Acute Myelogenous Leukemia
mitoxantrone
Resistant: D – Preclinical
mitoxantrone
Resistant
:
D
mitoxantrone
Resistant: D – Preclinical
mitoxantrone
Resistant
:
D
NSD1 mutation
Squamous Cell Carcinoma of Head and Neck
NSD1 mutation
Squamous Cell Carcinoma of Head and Neck
cisplatin
Sensitive: D – Preclinical
cisplatin
Sensitive
:
D
cisplatin
Sensitive: D – Preclinical
cisplatin
Sensitive
:
D
NUP98-NSD1 fusion + FLT3-ITD mutation
Acute Myelogenous Leukemia
NUP98-NSD1 fusion + FLT3-ITD mutation
Acute Myelogenous Leukemia
revumenib
Sensitive: D – Preclinical
revumenib
Sensitive
:
D
revumenib
Sensitive: D – Preclinical
revumenib
Sensitive
:
D
NUP98-NSD1 fusion
Acute Myelogenous Leukemia
NUP98-NSD1 fusion
Acute Myelogenous Leukemia
VTP-50469
Sensitive: D – Preclinical
VTP-50469
Sensitive
:
D
VTP-50469
Sensitive: D – Preclinical
VTP-50469
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.